Vittorio Gebbia

25PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 15, 2026
A Real-World Study on the Effectiveness and Safety of Elacestrant in Patients with ESR1-Mutated Metastatic Breast Cancer Progressing After CDK4/6 Inhibitors and Endocrine Therapy.

|Apr 27, 2026
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review.

|Mar 27, 2026
Scientific Meetings in Medical Oncology: Are We Facing a Time- and Resource-Consuming Plethora?

Vittorio Gebbia, Dario Piazza, Fabrizio Scrima

|Mar 14, 2026
From Feasibility to Individualization: Surgery for Breast Cancer Liver and Lung Metastases.

Martina Greco, Calogero Cipolla, Chiara Mesi

|Jan 10, 2026
Magnesium and Cancer Immunotherapy: A Narrative Practical Review.

Daniela Sambataro, Giuseppa Scandurra, Vittorio Gebbia

|Nov 27, 2025
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care.

Calogero Cipolla, Giuseppa Scandurra, Daniela Sambataro

Pageof 5

Frequent Collaborators

8 joint publications

Giuseppina Scandurra

8 joint publications

Daniela Sambataro

6 joint publications

Federica Martorana

3 joint publications

Dario Piazza